Russia (bbabo.net), - The Ministry of Health has approved clinical trials of the Russian coronavirus vaccine CoviVac for children, according to the state register of approved clinical trials.
The vaccine developers will conduct a double-blind, placebo-controlled, randomized trial to evaluate the tolerability, safety, and immunogenicity of the drug in children ranging in age from three to 17 years.
It is known that the number of volunteers will be 1,050 people, the total research will be carried out in four institutions - in Perm, Samara, the Moscow region and St. Petersburg.
Center them. Chumakova, who developed the vaccine, hopes that during this year he will receive permission to use KoviVac for preventive vaccination of children and adolescents, Aidar Ishmukhametov, director general of the center, corresponding member of the Russian Academy of Sciences, told TASS.
At the moment, in Russia it is allowed to vaccinate against coronavirus infection adolescents aged 12-17 years with the Sputnik M vaccine developed by the Center. Gamaleya. The drug is a five-fold diluted adult version of Sputnik V. Vaccination is carried out with the written consent and at the request of the child's parents.
bbabo.Net